Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Ariyan et al.
Cancer Immunology Research
Papers
April 2018
Authors and Affiliates
Charlotte E. Ariyan1, Mary Sue Brady1, Robert H. Siegelbaum2, Jian Hu1, Danielle M. Bello1, Jamie Rand1, Charles Fisher3, Robert A. Lefkowitz4, Kathleen S. Panageas5, Melissa Pulitzer6, Marissa Vignali7, Ryan Emerson7, Christopher Tipton7, Harlan Robins7, Taha Merghoub8, Jianda Yuan8, Achim Jungbluth6, Jorge Blando9, Padmanee Sharma9, Alexander Y. Rudensky10, Jedd D. Wolchok8,10, and James P. Allison9 1Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. 3Department of Anesthesia, Memorial Sloan Kettering Cancer Center, New York, New York. 4Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. 5Department of Statistics, Memorial Sloan Kettering Cancer Center, New York, New York. 6Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. 7Adaptive Biotechnology, Seattle, Washington. 8Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 9Department of Immunology, MD Anderson Cancer Center, Houston, Texas. 10Department of Immunology, Memorial Sloan Kettering Cancer Center, New York, New York.